METAGENICS METAPURE ALGAL OIL
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
14-06-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DHA/EPA rich Schizochytrium algal oil, Quantity: 962.7 mg (Equivalent: docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp., Qty 300 mg; Equivalent: eicosapentaenoic acid, Qty 150 mg)
Available from:
Metagenics (Aust) Pty Ltd
Pharmaceutical form:
Capsule, soft
Composition:
Excipient Ingredients: purified water; glycerol; hydroxypropyl starch; Rosemary Oil; Sunflower Oil; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate
Administration route:
Oral
Therapeutic indications:
Maintain/support general health and wellbeing ; Maintain/support cognitive function/mental function ; Maintain/support healthy pregnancy
Product summary:
Visual Identification: ;
Authorization status:
Listed
Authorization date:
2019-05-31
